Latest Financials News

Ovanti Limited advances its U.S. buy now, pay later ambitions through strategic partnerships and a proposed Nasdaq listing valued at US$300 million.

Alicanto Minerals has secured a transformative acquisition of the Mt Henry Gold Project in Western Australia, backed by a $28 million capital raise and a strategic partnership with Westgold. This move sets the stage for a major resource expansion and leadership refresh.

Minbos Resources Limited reported a challenging quarter with significant cash outflows but plans a $1 million share purchase plan to bolster its funding position.

Tissue Repair’s December quarter update reveals a cautious path forward for its Phase 3 TR987 trial amid slow patient recruitment, while its TR Pro+ product line gains momentum through a new distributor partnership and upcoming product launches.

Minbos Resources advances key financing deals and unveils a cost-cutting plan for its Cabinda Phosphate Project, while forming a strategic joint venture to develop green ammonia production targeting 2028.

Ragnar Metals has confirmed impressive high-grade gold assays at its Harnäs Gold Project in Sweden, paving the way for maiden diamond drilling in early 2026. Strategic investments in Australian gold producers further bolster its diversified portfolio amid record gold prices.

Bubs Australia reports a 14% increase in half-year revenue, powered by a 47% jump in US sales, while other regions face challenges. The company remains optimistic about FDA approval and market recovery in H2 FY26.

Gullewa Limited has increased its ownership in Central Iron Ore Limited to a controlling 70.5% by subscribing to a recent rights issue, acquiring over 23 million new shares.

EcoGraf Limited has marked significant progress in its Epanko Graphite Project financing and expansion plans, while initiating a strategic gold farm-in agreement with AngloGold Ashanti in Tanzania.

RBR Group Limited reports a significant uptick in tender opportunities exceeding US$80 million following the restart of major LNG projects in Mozambique, alongside steady contract revenues and ongoing infrastructure investments.

Recce Pharmaceuticals progresses its Phase 3 diabetic foot infection trial in Indonesia, reports promising preclinical data for inhaled RECCE 327, and secures significant R&D funding and patent protection.

Clime Investment Management appoints John Abernethy as Director of Investments, signalling a renewed focus on investment philosophy and client outcomes. Despite fund closures and regulatory challenges, the company reports improved fund returns and a promising interim profit outlook.